Target intelligence / Profile preview

Rotavirus VP7 (G3 serotype) (VP7)

Target
VP7
Molecular classification
Viral structural protein
01

Overview

Rotavirus VP7 is a calcium-stabilized trimeric glycoprotein forming the outermost layer of the rotavirus capsid with T=13 icosahedral symmetry, capping VP6 pillars on the double-layered particle (DLP). It displaces the transient ER membrane during maturation, locks VP4 spikes in place, and undergoes Ca2+ withdrawal-induced dissociation during cell entry to trigger VP4 conformational changes for membrane penetration. The G3 serotype (e.g., rhesus rotavirus RRV) features two domains: a Rossmann fold (domain I, residues ~78-161 and 256-321) and a jelly-roll beta-sandwich (domain II, residues ~161-256), with four intrasubunit disulfide bonds and two Ca2+ sites per subunit interface. The outward-facing surface bears neutralizing epitopes (regions 7-1 and 7-2) targeted by protective antibodies, which bind trimeric VP7 to prevent uncoating; the inward-facing surface interacts with VP6 via N-terminal arms. VP7 is a principal immunogen for vaccines, with disulfide-linked trimers proposed as stable subunit candidates.[1][2][3][4]

Other names
outer-layer protein VP7outer capsid protein VP7coat protein VP7
02

Mechanism of action

Neutralizing antibodies stabilize VP7 trimer to inhibit uncoating and VP4 rearrangement

03

Biological functions

Virion assemblyCapsid formationViral entryUncoating trigger
04

Disease associations

Infection

Beyond the preview

Go deeper on Rotavirus VP7 (G3 serotype) (VP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus VP7 (G3 serotype) (VP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call